Cargando…
Outcomes and characteristics of COVID-19 patients treated with continuous positive airway pressure/high-flow nasal oxygen outside the intensive care setting
BACKGROUND: Continuous positive airway pressure (CPAP) and high-flow nasal oxygen (HFNO) have been used to manage hypoxaemic respiratory failure secondary to coronavirus disease 2019 (COVID-19) pneumonia. Limited data are available for patients treated with noninvasive respiratory support outside of...
Autores principales: | Sykes, Dominic L., Crooks, Michael G., Thu Thu, Khaing, Brown, Oliver I., Tyrer, Theodore J.P., Rennardson, Jodie, Littlefield, Catherine, Faruqi, Shoaib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287575/ https://www.ncbi.nlm.nih.gov/pubmed/34611525 http://dx.doi.org/10.1183/23120541.00318-2021 |
Ejemplares similares
-
COVID-19 progression, frailty, and use of prolonged continuous positive airway pressure as a ward-based treatment: Lessons to be learnt from a case
por: Sykes, Dominic L, et al.
Publicado: (2021) -
Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective
por: Sykes, Dominic L., et al.
Publicado: (2021) -
Airway management: High flow nasal oxygenation
por: Kumar, Ajay, et al.
Publicado: (2016) -
High-flow nasal oxygen (HFNO) for patients with Covid-19 outside intensive care units
por: Issa, Issa, et al.
Publicado: (2021) -
It is time to end our love affair with short-acting β(2)-agonists in asthma
por: Crooks, Michael G., et al.
Publicado: (2022)